Orthopedic Implants Market Thumbnail Image

2023

Orthopedic Implants Market

Orthopedic Implants Market Size, Share, Competitive Landscape and Trend Analysis Report by Product Type (Reconstructive Joint Replacements, Spinal Implants, Dental Implants, Trauma, Orthobiologics, Others), by Biomaterial (Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials, Others), by Type (Knee, Hip, Wrist and Shoulder, Dental, Spine, Ankle, Others): Global Opportunity Analysis and Industry Forecast, 2022-2032

Select an option
Author's: Swapna Singh | Roshan Deshmukh
Publish Date:

Get Sample to Email

Orthopedic Implants Market Research, 2032

The global orthopedic implants market size was valued at $47,190.57 million in 2022, and is projected to reach $73,326.75 million by 2032, growing at a CAGR of 4.5% from 2023 to 2032. Orthopedic implants are devices that are placed inside or on the surface of the body, intended to replace missing body parts or provide support to organs and tissues. These devices are typically made of metal, plastic, or a combination of the two and are designed to mimic the function of the natural bone or joint they are replacing. Orthopedic implants are used in a wide range of procedures, including joint replacements, spinal surgeries, and fracture repairs.

Orthopedic Implants Market

“The orthopedic implants market was negatively impacted during the lockdown period owing to decrease in patient attendance at hospital visits, including preventive services such as screening of patients for various diseases and orthopedic disorders. In addition, cancellation of medical treatments and postponed orthopedic surgeries to stop the spread of COVID-19 infection hampered the growth of market.”

Market Dynamics

Growth & innovations in the pharmaceutical industry for launch of orthopedic implants owing to massive pool of health-conscious consumers, creates an opportunity for the orthopedic implants market size. Rise in launch of various orthopedic implants and rise in investments for manufacturing of advanced orthopedic implants by various key players across the globe is set to affect the market growth positively. In addition, a rise in

prevalence of orthopedic disorders and an increase in the number of surgeries is expected to drive the growth of the orthopedic implants market share. For instance, an article of National Health Service 2022 reported that 70,000 knee replacement surgeries are carried out every year. In addition, a rise in geriatric population is expected to drive the market growth, owing to rise in incidences of arthritic condition in aged population. Further, a rise in the number of musculoskeletal disorders is anticipated to drive the growth of the market. For instance, according to an article published in Taylor & Francis 2021, 64-92% of dentists reported musculoskeletal disorders, thus rise in musculoskeletal disorders in dentists is expected to drive the growth of the market.

Along with the factors mentioned above, technological advancements in the field of orthopedic implants such as the development of advanced implants are also expected to aid in the growth of orthopedic implants market share. Furthermore, various key players are adopting key strategies such as innovation and collaboration for advancements in orthopedic implants and offer advanced implant devices. For instance, in March 2022, Johnson & Johnson MedTech announced that DePuy Synthes, the orthopedics company of Johnson & Johnson, is adding two new innovations such as ATTUNE™ Knee portfolio: the ATTUNE™ Cementless Fixed Bearing Knee with AFFIXIUM™ 3DP Technology and the ATTUNE™ Medial Stabilized Knee System. Various organizations along with the government are counselling physicians and patients regarding orthopedic implants and their applications. In addition, rise in investments by various governments in digital technology for healthcare sector is expected to propel the growth of market. The demand for orthopedic implants is not only limited to developed countries but is also being witnessed in the developing countries, such as China, Brazil, and India, which fuels the growth of the market. Factors such as rise in adoption of orthopedic implants and increase in awareness toward use of orthopedic implants, further drive the market growth. Moreover, increase in promotional activities by manufacturers and growth in awareness about orthopedic implants and rise in number of trauma cases is expected to fuel their adoption in the near future.

However, factors such as high cost associated with procedures involving orthopedic implants treatment and stringent government policies regarding the implants are the factors which hamper the orthopedic implants market growth. In contrast, rise in technological advancements for development of advanced implants, rise in adoption of orthopedic implants, increase in awareness regarding orthopedic implants and favorable government policies for development of orthopedic implants are the factors that offer lucrative opportunities to the key players of the market.

The outbreak of COVID-19 has disrupted workflows in the health care sector around the world. The disease has forced several industries to shut down temporarily, including several sub-domains of health care. The pandemic reduced accessibility to and patient attendance at outpatient medical visits, including preventive services such as screening of patients for various diseases such orthopedic disorders. In addition, orthopedic doctors noted a marked decrease in patients visits during the lockdown. This was due to cancellation of medical treatments and postponing the orthopedic injuries to stop the spread of COVID-19 infection. For instance, according to report of Australian Orthopedic Association National Joint Replacement Registry 2021, stated that, joint replacement surgery declined by 5.7% in 2020 as compared to 2019. Thus, COVID-19 negatively impacted orthopedic implant market, owing to less patient visits for diagnosis and monitoring orthopedic disorders.

Segmental Overview

The orthopedic implants market is segmented into product, biomaterial, type, and region. By product, the market is segmented into reconstructive joint replacements, spinal implants, dental implants, trauma, orthobiologics, and others. By biomaterial, the market is segmented into metallic biomaterials, ceramic biomaterials, polymers biomaterials, and others. By type, the market is classified into knee, hip, wrist & shoulder, dental, spine, ankle, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Orthopedic Implants Market by Product Type

By product, the orthopedic implants industry is segmented into reconstructive joint replacements, spinal implants, dental implants, trauma, orthobiologics, and others. The reconstructive joint replacements segment accounted for the largest share in 2022 and is also expected to remain dominant during the orthopedic implants market forecast period, to rise in prevalence of osteoporosis,osteoarthritis and rise in number of key players offering orthopedic implants. The orthobiologics segment is projected to register highest CAGR during forecast period owing to a rise in research activities and technological advancements for development of orthobiologics and a rise in availability of orthobiologic products.

Orthopedic Implants Market by Biomaterial

By biomaterial, the orthopedic implants industry is segmented into metallic biomaterials, ceramic biomaterials, polymers biomaterials, and others. The metallic biomaterials segment occupied the highest share in 2022 owing to cost-effectiveness of these materials, provide efficacy of bone healing as compared to other materials and ideal for use in orthopedic trauma Implants devices such as joint replacements, bone plates and screws used in fractures. However, the other segment is estimated to register the highest CAGR during the forecast period owing to rise in adoption of these materials and increased R&D activities to study their application in orthopedic implants.

Orthopedic Implants Market by Type

By type the market is classified into knee, hip, wrist & shoulder, dental, spine, ankle, and others. The knee segment occupied the highest share in 2022 owing to rise in prevalence of orthopedic diseases such as rheumatoid arthritis and osteoarthritis. However, spine segment is estimated to register the highest CAGR during the forecast period owing to increase in geriatric population, rise in incidence of spinal disorders, and expansion in the indications for which spinal fusion surgery is performed.

Orthopedic Implants Market by Region

By region wise, North America accounted for a majority of the global orthopedic implant market share in 2020 and is anticipated to remain dominant during the forecast period. This is attributed to increase in prevalence of orthopedic disorders, rise in geriatric population, high healthcare expenditure, and presence of major key players offering advanced orthopedic trauma implants. However, Asia-Pacific is anticipated to witness notable growth, owing to rise in R&D activities, increase in prevalence of arthritis & sport related injuries, unmet medical demands, and increase in investments in the healthcare sector in the region.

Presence of several major players, such as Johnson & Johnson (DEPUY SYNTHES), Smith & Nephew plc, Stryker Corporation and Zimmer Biomet Holdings Inc, and advancement in orthopedic implants for development of effective implants in the region is expected to drive the growth of the market. Furthermore, the presence of well-established healthcare infrastructure, and rise in availability of advanced orthopedic implants are expected to drive the market growth. Furthermore, various product launches and rise in investments in orthopedic implants as key strategies adopted by

the key players in this region further boost the growth of the market. For instance, in December 2022, Arthrex, a global leader in minimally invasive orthopedic technology, launched the award-winning Arthrex Minimally Invasive Bunionectomy System to offer patients a better solution to traditional bunion surgery. Thus, such a product launch is expected to drive the growth of the market.

Asia-Pacific is expected to grow at the highest rate during the forecast period. The market growth in this region is attributable to the presence of key players in the region. Moreover, a rise in the prevalence of sport-related injuries and fractures is anticipated to contribute to the growth of the market. Further, with rapid development of digital technology in health and vast market demand for advanced orthopedic implants in India & China, which is anticipated to contribute to growth of market. Asia-Pacific offers profitable opportunities for key players operating in the orthopedic implants market, thereby registering the fastest growth rate during the forecast period, owing to the growing infrastructure of industries, as well as well-established presence of domestic companies in the region. In addition, the rise in contract manufacturing organizations within the region provides great opportunity for new entrants in this region.

Competitive Analysis

Competitive analysis and profiles of the major players in the orthopedic implants market, such as Arthrex, Inc., Colfax Corporation (DJO, LLC), CONMED CORPORATION, GLOBUS MEDICAL INC., Johnson & Johnson (DEPUY SYNTHES), Medtronic Plc, NuVasive Inc., Smith & Nephew plc, Stryker Corporation and Zimmer Biomet Holdings Incare provided in this report. Major players have adopted product launch, acquisition, collaboration, and innovation as key developmental strategies to improve the products of the orthopedic implants market.

Some Examples of Acquisition in The Market

In June 2022, CONMED Corporation) announced that it has completed its previously announced acquisition of privately held In2Bones Global Inc., global developer, manufacturer, and distributor of medical devices for the treatment of disorders and injuries of the upper (hand, wrist, elbow) and lower (foot and ankle) extremities. The company’s comprehensive product portfolio includes implants, fracture systems, biologics, and related hardware.

Product Launch in The Market

In October 2022, Stryker, one of the world’s leading medical technology companies, launched the Monterey AL Interbody System, a stand-alone interbody fusion device designed for anterior lumbar interbody fusion (ALIF).

In January 2023, Enovis Corporation, an innovation-driven medical technology company, announced the launch of the DynaClip Delta™ and DynaClip Quattro™ bone staples, the latest additions to the Company’s growing foot and ankle portfolio and the DynaClip® family of bone fixation systems.

Product Approval in The Market

In October 2022, Johnson & Johnson MedTech announced that DePuy Synthes, the orthopedics company of Johnson & Johnson, has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its TELIGEN™ System, an integrated technology platform that enables minimally invasive surgical transforaminal lumbar interbody fusion (MIS-TLIF) procedures through digital tools for visualization and access.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the orthopedic implants market analysis from 2022 to 2032 to identify the prevailing orthopedic implants market opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the orthopedic implants market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global orthopedic implants market trends, key players, market segments, application areas, and market growth strategies.

Orthopedic Implants Market Report Highlights

Aspects Details
Market Size By 2032
Market Size By 2032

USD 73.3 billion

Growth Rate
Growth Rate

CAGR of 4.5%

Forecast period
Forecast period

2022 - 2032

Report Pages
Report Pages

210

Orthopedic Implants Market By Product Type
By Product Type
  • Reconstructive Joint Replacements
    • Type
      • Knee Replacement Implants
      • Hip Replacement Implants
      • Extremities
        • Type
          • Upper Extremity Reconstruction
  • Spinal Implants
    • Type
      • Spinal fusion implants
        • Type
          • Thoracolumbar devices
          • Cervical fixation devices
          • Interbody fusion devices
      • Invasive Spinal bone stimulators
      • Vertebral Compression Fracture (VCF) Devices
        • Type
          • Balloon Kyphoplasty Devices
          • Vertebroplasty Devices
      • Motion Preservation Devices/Non-Fusion Devices
        • Type
          • Dynamic Stabilization Devices
          • Artificial Disc Replacement Devices
          • Annulus Repair Devices
          • Nuclear Disc Prostheses
  • Dental Implants
    • Type
      • Root Form Dental Implants
      • Plate Form Dental Implants
  • Trauma
  • Orthobiologics
    • Type
      • Demineralized Bone Matrix (DBM)
      • Allograft
      • Bone Morphogenetic Protein (BMP)
      • Viscosupplementation Products
      • Synthetic Bone Substitutes
      • Others
  • Others
Orthopedic Implants Market By Biomaterial
By Biomaterial
  • Metallic Biomaterials
    • Type
      • Stainless steel
      • Titanium Alloy
      • Cobalt Alloy
      • Others
  • Ceramic Biomaterials
  • Polymeric Biomaterials
  • Others
Orthopedic Implants Market By Type
By Type
  • Wrist and Shoulder
  • Dental
  • Spine
  • Ankle
  • Others
  • Knee
  • Hip
Orthopedic Implants Market By Region
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players
Key Market Players

Arthrex, Inc., NuVasive Inc., Colfax Corporation (DJO GLOBAL LLC), Stryker Corporation, Globus Medical, Inc., Medtronic plc, Smith & Nephew plc, Johnson & Johnson, Zimmer Biomet Holdings Inc., CONMED Corporation

Analyst Review

This section provides various opinions of top-level CXOs in the global orthopedic implants market. According to the insights of CXOs, increase in demand for advanced orthopedic implants such as robot-assisted orthopedic systems and 3D orthopedic systems) and rise in investments for development of innovative implants, globally is expected to offer profitable opportunities for the expansion of the market. In addition, favorable government initiatives and higher spending for orthopedic implants have piqued the interest of several companies to develop orthopedic implants.

CXOs further added that increase in prevalence of orthopedic diseases and surge in geriatric population across the globe, and rise in acceptance of orthopedic implants, are factors expected to boost the growth of the market. In addition, increasing technological advancements and improvement in healthcare infrastructure in emerging nations further drive the growth of the market. Further, the rise in adoption of key strategies such as new product launches and various collaborations for development of advanced orthopedic implant, drives the growth of the market.

Furthermore, North America accounted for a majority of the global orthopedic implant market share in 2020 and is anticipated to remain dominant during the forecast period. This is attributed to increase in prevalence of orthopedic disorders, rise in geriatric population, high healthcare expenditure, and presence of major key players offering advanced orthopedic implants. However, Asia-Pacific is anticipated to witness notable growth, owing to rise in R&D activities, increase in prevalence of arthritis & sport related injuries, unmet medical demands, and increase in investments in the healthcare sector in the region.

Author Name(s) : Swapna Singh | Roshan Deshmukh
Frequently Asked Questions?

The major factor that fuels the growth of the orthopedic implants market are rise in prevalence of orthopedic injuries such as arthritis, osteoarthritis as well as rapid increase in the aging population globally who are more prone to orthopedic diseases.

Reconstructive joint replacements is the most influencing application in orthopedic implants market which is attributed to rise in prevalence of osteoporosis and osteoarthritis and investment by key players in R&D of orthopedic implants.

North America is the largest regional market for Orthopedic Implants.

The total market value of orthopedic implants market is $47,190.57 million in 2022.

Top companies such as Johnson & Johnson, Zimmer Biomet Holdings, Inc., Stryker Corporation, Globus Medical Inc, and Smith & Nephew plc held a high market position in 2022. These key players held a high market position owing to the strong geographical foothold in different regions.

The base year is 2022 in orthopedic implants market.

The forecast period for orthopedic implants market is 2023 to 2032.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Orthopedic Implants Market

Global Opportunity Analysis and Industry Forecast, 2022-2032